张俊杰

博士后

张俊杰

博士后
  • 教育经历

2013.9-2021.6 中南大学 湘雅医学院 临床医学八年制

  • 工作经历

2021.10-至今 中南大学湘雅医院 精准分子医学研究所 博士后/助理研究员

2022.7-至今 中南大学湘雅医院胸外科 医师

  • 研究方向

临床研究,肺腺癌,铜死亡,免疫/靶向治疗

  • 获得奖励

联邦教育奖励金博士生一等奖(2020)

中华医学会泌尿外科学年会优秀论文两篇(2019)国家励志奖学金(2017)

全国大学生英语竞赛三等奖(2014)

  • 文章发表

1. Zhang J, Zhang M, Tang J, Yin G, Long Z, He L, et al. Animal models of benign prostatic hyperplasia. Prostate cancer and prostatic diseases. 2021;24(1):49-57. Review 第一作者
2. Zhang J, Ou Z, Zhang X, He W, Wang R, Mo M, et al. Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results. World journal of urology. 2020;38(6):1555-62. Article 第一作者
3. Zhang J, Zhang M, Zhang Y, Liu H, Yuan P, Peng X, et al. Proposal of the 3O (Obstruction, Ureteric Orifice, and Outcome) Subclassification System Associated with Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA). Journal of pediatric and adolescent gynecology. 2020;33(3):307-13. Article 第一作者
4. Zhang J, Wang L. Dysplastic kidney and ectopic ureter in association with obstructed hemivagina and ipsilateral renal anomaly. International urogynecology journal. 2020;31(8):1707-9. Case report 第一作者
5. Zhang J, Zhang Y, Wang L. Response to the Comment on: Proposal of the 3O (Obstruction, Ureteric Orifice, and Outcome) Subclassification System Associated with Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA). Journal of pediatric and adolescent gynecology. 2020;33(6):710-1. Letter 第一作者
6. Zhang JJ, Shi X, Wu T, Zhang MD, Tang J, Yin GM, et al. Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis. (1745-7262 (Electronic)). Article 第一作者